A Study of YY-20394 in Participants With Relapsed/Refractory Follicular Non-Hodgkin's Lymphoma

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
This is a study designed to evaluate the efficacy and safety of oral YY-20394 in patients with R/R follicular non-Hodgkin\'s lymphoma who have failed at least two prior systemic therapies.
Epistemonikos ID: aae8195bf88a6bf19d4187d772563097ac552105
First added on: May 07, 2024